Vaidam Health Goes to Canada’s Ivey Business School

S Singh
S Singh
· 2 min read
stock NEET PG Results

Gurugram-based start-up Vaidam Health, India’s premier online platform for medical tourists established by two IIM graduates, has now become the subject of a case study by Ivey Business School, one of the oldest business schools in Canada whose MBA program is ranked among the world’s best.

Manish Chandra, Co-founder, Vaidam Health said, “Though Ivey Business School publishes about 350 case studies each year focusing on businesses around the world, very few actually relate to India. We are therefore extremely delighted that this prestigious B school has chosen to publish a case study on Vaidam Health for study by MBA students worldwide, and our company may be taught as a part of their curriculum. This is a huge achievement and a vindication of our business model and future growth potential considering that we started our operations hardly three years ago.”

Vaidam Health, which raised angel funding in 2016 from Singapore-based 4CE Ventures, has been certified to ISO 9001 and 27001 standards as a web-based medical tourism facilitator. It is also India’s first and only online platform for medical tourists to get accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH). The portal (www.vaidam.com) is a healthcare facilitator connecting foreign patients with the best accredited healthcare specialists and hospitals in India for treatment at an affordable price.

Ivey cases are highly prized by the academic community for meeting the rigorous demands of management education. They are real-world cases, typically field-based, involving actual interviews with businesses from around the world. Unlike Harvard, however, whose case studies are written by its own professors, authors of Ivey case studies can come from any business school in the world, making the works representative of what’s being used and selected by professors in the wider world.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk